Faculty of Pharmacy, University of Ljubljana, Askerceva 7, SI-1000 Ljubljana, Slovenia.
Int J Pharm. 2009 Nov 3;381(2):153-9. doi: 10.1016/j.ijpharm.2009.07.009. Epub 2009 Jul 17.
The rate of dissolution of drugs remains one of the most challenging aspects in formulation development of poorly water-soluble drugs. The meloxicam, a low molecular analgetic for oral administration, exhibits a slow dissolution. To improve the dissolution rate, the drug was formulated in a nanosuspension by using an emulsion-diffusion method, high-pressure homogenization or sonication. Optimization of the technological parameters (organic solvents, stabilizers, homogenization procedure and recovery of particles) allowed the formation of nanosuspensions with a particle size of 200-900 nm. SEM imaging confirmed the nanosized drug particles. Use of an SMCR method on the XRPD patterns of the nanosuspensions revealed the crystalline form of the drug and the strong interaction between meloxicam and the stabilizer. The rate of dissolution of the dried meloxicam nanosuspension was enhanced (90% in 5 min), relative to that of raw meloxicam (15% in 5 min), mainly due to the formation of nanosized particles. These results indicate the suitability of formulation procedure for preparation of nanosized poorly water-soluble drug with significantly improved in vitro dissolution rate, and thus possibly enhance fast onset of therapeutic drug effect.
药物的溶出率仍然是开发难溶性药物制剂时最具挑战性的方面之一。美洛昔康是一种低分子口服镇痛药,其溶解速度较慢。为了提高溶出率,将该药物通过乳化扩散法、高压匀质或超声处理制成纳米混悬剂。通过优化工艺参数(有机溶剂、稳定剂、匀质程序和颗粒回收),可以形成粒径为 200-900nm 的纳米混悬剂。SEM 成像证实了药物的纳米级颗粒。对纳米混悬剂的 X 射线粉末衍射图谱使用 SMCR 方法表明了药物的晶型和美洛昔康与稳定剂之间的强相互作用。干燥的美洛昔康纳米混悬剂的溶出率得到了提高(5 分钟内提高了 90%),相对于原料药(5 分钟内提高了 15%),这主要是由于形成了纳米级颗粒。这些结果表明,该制剂方法适用于制备具有显著提高体外溶出率的难溶性纳米药物,从而可能增强治疗药物的快速起效。